I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Global Competitor Market Shares
Cell Viability Assays Competitor Market Share Scenario
Worldwide (in %): 2019 & 2025
Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: Cell Viability Assays Global Market Estimates and
Forecasts in US$ Million by Region/Country: 2020-2027

Table 2: Cell Viability Assays Global Retrospective Market
Scenario in US$ Million by Region/Country: 2012-2019

Table 3: Cell Viability Assays Market Share Shift across Key
Geographies Worldwide: 2012 VS 2020 VS 2027

Table 4: Consumables (Product Type) World Market by
Region/Country in US$ Million: 2020 to 2027

Table 5: Consumables (Product Type) Historic Market Analysis by
Region/Country in US$ Million: 2012 to 2019

Table 6: Consumables (Product Type) Market Share Breakdown of
Worldwide Sales by Region/Country: 2012 VS 2020 VS 2027

Table 7: Instruments (Product Type) Potential Growth Markets
Worldwide in US$ Million: 2020 to 2027

Table 8: Instruments (Product Type) Historic Market Perspective
by Region/Country in US$ Million: 2012 to 2019

Table 9: Instruments (Product Type) Market Sales Breakdown by
Region/Country in Percentage: 2012 VS 2020 VS 2027

Table 10: Basic Research (Application) Global Market Estimates &
Forecasts in US$ Million by Region/Country: 2020-2027

Table 11: Basic Research (Application) Retrospective Demand
Analysis in US$ Million by Region/Country: 2012-2019

Table 12: Basic Research (Application) Market Share Breakdown
by Region/Country: 2012 VS 2020 VS 2027

Table 13: Stem Cell Research (Application) Demand Potential
Worldwide in US$ Million by Region/Country: 2020-2027

Table 14: Stem Cell Research (Application) Historic Sales
Analysis in US$ Million by Region/Country: 2012-2019

Table 15: Stem Cell Research (Application) Share Breakdown
Review by Region/Country: 2012 VS 2020 VS 2027

Table 16: Drug Discovery & Development (Application) Worldwide
Latent Demand Forecasts in US$ Million by Region/Country:
2020-2027

Table 17: Drug Discovery & Development (Application) Global
Historic Analysis in US$ Million by Region/Country: 2012-2019

Table 18: Drug Discovery & Development (Application)
Distribution of Global Sales by Region/Country: 2012 VS 2020 VS
2027

Table 19: Clinical & Diagnostic Applications (Application)
Sales Estimates and Forecasts in US$ Million by Region/Country
for the Years 2020 through 2027

Table 20: Clinical & Diagnostic Applications (Application)
Analysis of Historic Sales in US$ Million by Region/Country for
the Years 2012 to 2019

Table 21: Clinical & Diagnostic Applications (Application)
Global Market Share Distribution by Region/Country for 2012,
2020, and 2027

Table 22: Other Applications (Application) Global Opportunity
Assessment in US$ Million by Region/Country: 2020-2027

Table 23: Other Applications (Application) Historic Sales
Analysis in US$ Million by Region/Country: 2012-2019

Table 24: Other Applications (Application) Percentage Share
Breakdown of Global Sales by Region/Country: 2012 VS 2020 VS
2027

Table 25: Academic & Research Institutes (End-Use) Worldwide
Sales in US$ Million by Region/Country: 2020-2027

Table 26: Academic & Research Institutes (End-Use) Historic
Demand Patterns in US$ Million by Region/Country: 2012-2019

Table 27: Academic & Research Institutes (End-Use) Market Share
Shift across Key Geographies: 2012 VS 2020 VS 2027

Table 28: Pharmaceutical & Biotechnology Companies (End-Use)
Global Market Estimates & Forecasts in US$ Million by
Region/Country: 2020-2027

Table 29: Pharmaceutical & Biotechnology Companies (End-Use)
Retrospective Demand Analysis in US$ Million by Region/Country:
2012-2019

Table 30: Pharmaceutical & Biotechnology Companies (End-Use)
Market Share Breakdown by Region/Country: 2012 VS 2020 VS 2027

Table 31: Hospital & Diagnostic Laboratories (End-Use) Demand
Potential Worldwide in US$ Million by Region/Country: 2020-2027

Table 32: Hospital & Diagnostic Laboratories (End-Use) Historic
Sales Analysis in US$ Million by Region/Country: 2012-2019

Table 33: Hospital & Diagnostic Laboratories (End-Use) Share
Breakdown Review by Region/Country: 2012 VS 2020 VS 2027

Table 34: Other End-Uses (End-Use) Worldwide Latent Demand
Forecasts in US$ Million by Region/Country: 2020-2027

Table 35: Other End-Uses (End-Use) Global Historic Analysis in
US$ Million by Region/Country: 2012-2019

Table 36: Other End-Uses (End-Use) Distribution of Global Sales
by Region/Country: 2012 VS 2020 VS 2027

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

UNITED STATES
Market Facts & Figures
US Cell Viability Assays Market Share (in %) by Company: 2019 &
2025
Market Analytics
Table 37: United States Cell Viability Assays Market Estimates
and Projections in US$ Million by Product Type: 2020 to 2027

Table 38: Cell Viability Assays Market in the United States by
Product Type: A Historic Review in US$ Million for 2012-2019

Table 39: United States Cell Viability Assays Market Share
Breakdown by Product Type: 2012 VS 2020 VS 2027

Table 40: United States Cell Viability Assays Latent Demand
Forecasts in US$ Million by Application: 2020 to 2027

Table 41: Cell Viability Assays Historic Demand Patterns in the
United States by Application in US$ Million for 2012-2019

Table 42: Cell Viability Assays Market Share Breakdown in the
United States by Application: 2012 VS 2020 VS 2027

Table 43: United States Cell Viability Assays Latent Demand
Forecasts in US$ Million by End-Use: 2020 to 2027

Table 44: Cell Viability Assays Historic Demand Patterns in the
United States by End-Use in US$ Million for 2012-2019

Table 45: Cell Viability Assays Market Share Breakdown in the
United States by End-Use: 2012 VS 2020 VS 2027

CANADA
Table 46: Canadian Cell Viability Assays Market Estimates and
Forecasts in US$ Million by Product Type: 2020 to 2027

Table 47: Canadian Cell Viability Assays Historic Market Review
by Product Type in US$ Million: 2012-2019

Table 48: Cell Viability Assays Market in Canada: Percentage
Share Breakdown of Sales by Product Type for 2012, 2020, and
2027

Table 49: Canadian Cell Viability Assays Market Quantitative
Demand Analysis in US$ Million by Application: 2020 to 2027

Table 50: Cell Viability Assays Market in Canada: Summarization
of Historic Demand Patterns in US$ Million by Application for
2012-2019

Table 51: Canadian Cell Viability Assays Market Share Analysis
by Application: 2012 VS 2020 VS 2027

Table 52: Canadian Cell Viability Assays Market Quantitative
Demand Analysis in US$ Million by End-Use: 2020 to 2027

Table 53: Cell Viability Assays Market in Canada: Summarization
of Historic Demand Patterns in US$ Million by End-Use for
2012-2019

Table 54: Canadian Cell Viability Assays Market Share Analysis
by End-Use: 2012 VS 2020 VS 2027

JAPAN
Table 55: Japanese Market for Cell Viability Assays: Annual
Sales Estimates and Projections in US$ Million by Product Type
for the Period 2020-2027

Table 56: Cell Viability Assays Market in Japan: Historic Sales
Analysis in US$ Million by Product Type for the Period
2012-2019

Table 57: Japanese Cell Viability Assays Market Share Analysis
by Product Type: 2012 VS 2020 VS 2027

Table 58: Japanese Demand Estimates and Forecasts for Cell
Viability Assays in US$ Million by Application: 2020 to 2027

Table 59: Japanese Cell Viability Assays Market in US$ Million
by Application: 2012-2019

Table 60: Cell Viability Assays Market Share Shift in Japan by
Application: 2012 VS 2020 VS 2027

Table 61: Japanese Demand Estimates and Forecasts for Cell
Viability Assays in US$ Million by End-Use: 2020 to 2027

Table 62: Japanese Cell Viability Assays Market in US$ Million
by End-Use: 2012-2019

Table 63: Cell Viability Assays Market Share Shift in Japan by
End-Use: 2012 VS 2020 VS 2027

CHINA
Table 64: Chinese Cell Viability Assays Market Growth Prospects
in US$ Million by Product Type for the Period 2020-2027

Table 65: Cell Viability Assays Historic Market Analysis in
China in US$ Million by Product Type: 2012-2019

Table 66: Chinese Cell Viability Assays Market by Product Type:
Percentage Breakdown of Sales for 2012, 2020, and 2027

Table 67: Chinese Demand for Cell Viability Assays in US$
Million by Application: 2020 to 2027

Table 68: Cell Viability Assays Market Review in China in US$
Million by Application: 2012-2019

Table 69: Chinese Cell Viability Assays Market Share Breakdown
by Application: 2012 VS 2020 VS 2027

Table 70: Chinese Demand for Cell Viability Assays in US$
Million by End-Use: 2020 to 2027

Table 71: Cell Viability Assays Market Review in China in US$
Million by End-Use: 2012-2019

Table 72: Chinese Cell Viability Assays Market Share Breakdown
by End-Use: 2012 VS 2020 VS 2027

EUROPE
Market Facts & Figures
European Cell Viability Assays Market: Competitor Market Share
Scenario (in %) for 2019 & 2025
Market Analytics
Table 73: European Cell Viability Assays Market Demand Scenario
in US$ Million by Region/Country: 2020-2027

Table 74: Cell Viability Assays Market in Europe: A Historic
Market Perspective in US$ Million by Region/Country for the
Period 2012-2019

Table 75: European Cell Viability Assays Market Share Shift by
Region/Country: 2012 VS 2020 VS 2027

Table 76: European Cell Viability Assays Market Estimates and
Forecasts in US$ Million by Product Type: 2020-2027

Table 77: Cell Viability Assays Market in Europe in US$ Million
by Product Type: A Historic Review for the Period 2012-2019

Table 78: European Cell Viability Assays Market Share Breakdown
by Product Type: 2012 VS 2020 VS 2027

Table 79: European Cell Viability Assays Addressable Market
Opportunity in US$ Million by Application: 2020-2027

Table 80: Cell Viability Assays Market in Europe: Summarization
of Historic Demand in US$ Million by Application for the Period
2012-2019

Table 81: European Cell Viability Assays Market Share Analysis
by Application: 2012 VS 2020 VS 2027

Table 82: European Cell Viability Assays Addressable Market
Opportunity in US$ Million by End-Use: 2020-2027

Table 83: Cell Viability Assays Market in Europe: Summarization
of Historic Demand in US$ Million by End-Use for the Period
2012-2019

Table 84: European Cell Viability Assays Market Share Analysis
by End-Use: 2012 VS 2020 VS 2027

FRANCE
Table 85: Cell Viability Assays Market in France by Product
Type: Estimates and Projections in US$ Million for the Period
2020-2027

Table 86: French Cell Viability Assays Historic Market Scenario
in US$ Million by Product Type: 2012-2019

Table 87: French Cell Viability Assays Market Share Analysis by
Product Type: 2012 VS 2020 VS 2027

Table 88: Cell Viability Assays Quantitative Demand Analysis in
France in US$ Million by Application: 2020-2027

Table 89: French Cell Viability Assays Historic Market Review
in US$ Million by Application: 2012-2019

Table 90: French Cell Viability Assays Market Share Analysis:
A 17-Year Perspective by Application for 2012, 2020, and 2027

Table 91: Cell Viability Assays Quantitative Demand Analysis in
France in US$ Million by End-Use: 2020-2027

Table 92: French Cell Viability Assays Historic Market Review
in US$ Million by End-Use: 2012-2019

Table 93: French Cell Viability Assays Market Share Analysis:
A 17-Year Perspective by End-Use for 2012, 2020, and 2027

GERMANY
Table 94: Cell Viability Assays Market in Germany: Recent Past,
Current and Future Analysis in US$ Million by Product Type for
the Period 2020-2027

Table 95: German Cell Viability Assays Historic Market Analysis
in US$ Million by Product Type: 2012-2019

Table 96: German Cell Viability Assays Market Share Breakdown
by Product Type: 2012 VS 2020 VS 2027

Table 97: Cell Viability Assays Market in Germany: Annual Sales
Estimates and Forecasts in US$ Million by Application for the
Period 2020-2027

Table 98: German Cell Viability Assays Market in Retrospect in
US$ Million by Application: 2012-2019

Table 99: Cell Viability Assays Market Share Distribution in
Germany by Application: 2012 VS 2020 VS 2027

Table 100: Cell Viability Assays Market in Germany: Annual
Sales Estimates and Forecasts in US$ Million by End-Use for the
Period 2020-2027

Table 101: German Cell Viability Assays Market in Retrospect in
US$ Million by End-Use: 2012-2019

Table 102: Cell Viability Assays Market Share Distribution in
Germany by End-Use: 2012 VS 2020 VS 2027

ITALY
Table 103: Italian Cell Viability Assays Market Growth
Prospects in US$ Million by Product Type for the Period
2020-2027

Table 104: Cell Viability Assays Historic Market Analysis in
Italy in US$ Million by Product Type: 2012-2019

Table 105: Italian Cell Viability Assays Market by Product
Type: Percentage Breakdown of Sales for 2012, 2020, and 2027

Table 106: Italian Demand for Cell Viability Assays in US$
Million by Application: 2020 to 2027

Table 107: Cell Viability Assays Market Review in Italy in US$
Million by Application: 2012-2019

Table 108: Italian Cell Viability Assays Market Share Breakdown
by Application: 2012 VS 2020 VS 2027

Table 109: Italian Demand for Cell Viability Assays in US$
Million by End-Use: 2020 to 2027

Table 110: Cell Viability Assays Market Review in Italy in US$
Million by End-Use: 2012-2019

Table 111: Italian Cell Viability Assays Market Share Breakdown
by End-Use: 2012 VS 2020 VS 2027

UNITED KINGDOM
Table 112: United Kingdom Market for Cell Viability Assays:
Annual Sales Estimates and Projections in US$ Million by
Product Type for the Period 2020-2027

Table 113: Cell Viability Assays Market in the United Kingdom:
Historic Sales Analysis in US$ Million by Product Type for the
Period 2012-2019

Table 114: United Kingdom Cell Viability Assays Market Share
Analysis by Product Type: 2012 VS 2020 VS 2027

Table 115: United Kingdom Demand Estimates and Forecasts for
Cell Viability Assays in US$ Million by Application: 2020 to
2027

Table 116: United Kingdom Cell Viability Assays Market in US$
Million by Application: 2012-2019

Table 117: Cell Viability Assays Market Share Shift in the
United Kingdom by Application: 2012 VS 2020 VS 2027

Table 118: United Kingdom Demand Estimates and Forecasts for
Cell Viability Assays in US$ Million by End-Use: 2020 to 2027

Table 119: United Kingdom Cell Viability Assays Market in US$
Million by End-Use: 2012-2019

Table 120: Cell Viability Assays Market Share Shift in the
United Kingdom by End-Use: 2012 VS 2020 VS 2027

REST OF EUROPE
Table 121: Rest of Europe Cell Viability Assays Market
Estimates and Forecasts in US$ Million by Product Type:
2020-2027

Table 122: Cell Viability Assays Market in Rest of Europe in
US$ Million by Product Type: A Historic Review for the Period
2012-2019

Table 123: Rest of Europe Cell Viability Assays Market Share
Breakdown by Product Type: 2012 VS 2020 VS 2027

Table 124: Rest of Europe Cell Viability Assays Addressable
Market Opportunity in US$ Million by Application: 2020-2027

Table 125: Cell Viability Assays Market in Rest of Europe:
Summarization of Historic Demand in US$ Million by Application
for the Period 2012-2019

Table 126: Rest of Europe Cell Viability Assays Market Share
Analysis by Application: 2012 VS 2020 VS 2027

Table 127: Rest of Europe Cell Viability Assays Addressable
Market Opportunity in US$ Million by End-Use: 2020-2027

Table 128: Cell Viability Assays Market in Rest of Europe:
Summarization of Historic Demand in US$ Million by End-Use for
the Period 2012-2019

Table 129: Rest of Europe Cell Viability Assays Market Share
Analysis by End-Use: 2012 VS 2020 VS 2027

ASIA-PACIFIC
Table 130: Cell Viability Assays Market in Asia-Pacific by
Product Type: Estimates and Projections in US$ Million for the
Period 2020-2027

Table 131: Asia-Pacific Cell Viability Assays Historic Market
Scenario in US$ Million by Product Type: 2012-2019

Table 132: Asia-Pacific Cell Viability Assays Market Share
Analysis by Product Type: 2012 VS 2020 VS 2027

Table 133: Cell Viability Assays Quantitative Demand Analysis
in Asia-Pacific in US$ Million by Application: 2020-2027

Table 134: Asia-Pacific Cell Viability Assays Historic Market
Review in US$ Million by Application: 2012-2019

Table 135: Asia-Pacific Cell Viability Assays Market Share
Analysis: A 17-Year Perspective by Application for 2012, 2020,
and 2027

Table 136: Cell Viability Assays Quantitative Demand Analysis
in Asia-Pacific in US$ Million by End-Use: 2020-2027

Table 137: Asia-Pacific Cell Viability Assays Historic Market
Review in US$ Million by End-Use: 2012-2019

Table 138: Asia-Pacific Cell Viability Assays Market Share
Analysis: A 17-Year Perspective by End-Use for 2012, 2020, and
2027

REST OF WORLD
Table 139: Rest of World Cell Viability Assays Market Estimates
and Forecasts in US$ Million by Product Type: 2020 to 2027

Table 140: Rest of World Cell Viability Assays Historic Market
Review by Product Type in US$ Million: 2012-2019

Table 141: Cell Viability Assays Market in Rest of World:
Percentage Share Breakdown of Sales by Product Type for 2012,
2020, and 2027

Table 142: Rest of World Cell Viability Assays Market
Quantitative Demand Analysis in US$ Million by Application:
2020 to 2027

Table 143: Cell Viability Assays Market in Rest of World:
Summarization of Historic Demand Patterns in US$ Million by
Application for 2012-2019

Table 144: Rest of World Cell Viability Assays Market Share
Analysis by Application: 2012 VS 2020 VS 2027

Table 145: Rest of World Cell Viability Assays Market
Quantitative Demand Analysis in US$ Million by End-Use: 2020 to
2027

Table 146: Cell Viability Assays Market in Rest of World:
Summarization of Historic Demand Patterns in US$ Million by
End-Use for 2012-2019

Table 147: Rest of World Cell Viability Assays Market Share
Analysis by End-Use: 2012 VS 2020 VS 2027

IV. COMPETITION
Total Companies Profiled: 46